CARREFOUR SA/S (OTCMKTS:CRRFY) Lifted to Hold at Zacks Investment Research

Share on StockTwits

CARREFOUR SA/S (OTCMKTS:CRRFY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Wednesday, Zacks.com reports.

According to Zacks, “Carrefour S.A. operates hypermarkets, supermarkets, convenience stores and cash and carry stores in Europe, the Americas and Asia. Carrefour S.A. is headquartered in Boulogne-Billancourt, France. “

CRRFY traded down $0.05 during trading on Wednesday, reaching $3.26. The stock had a trading volume of 231,737 shares, compared to its average volume of 231,305. The firm has a market capitalization of $13.02 billion, a price-to-earnings ratio of 11.64, a price-to-earnings-growth ratio of 1.09 and a beta of 0.82. CARREFOUR SA/S has a 1-year low of $3.18 and a 1-year high of $4.15. The stock has a 50 day moving average of $3.42 and a two-hundred day moving average of $3.60.

CARREFOUR SA/S Company Profile

Carrefour SA operates stores in various formats and channels in France, Spain, Italy, Belgium, Poland, Romania, Brazil, Argentina, China, and Taiwan. The company operates hypermarkets, supermarkets, cash and carry stores, and hypercash stores; e-commerce sites and m-commerce channels; and service stations.

Further Reading: 52 Week Highs and Lows

Get a free copy of the Zacks research report on CARREFOUR SA/S (CRRFY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for CARREFOUR SA/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CARREFOUR SA/S and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Analysts Set $33.00 Target Price for SpringWorks Therapeutics
Analysts Set $33.00 Target Price for SpringWorks Therapeutics
Ardelyx Inc  Given Consensus Rating of “Hold” by Analysts
Ardelyx Inc Given Consensus Rating of “Hold” by Analysts
Western Midstream Partners LP  Receives $32.25 Consensus Price Target from Analysts
Western Midstream Partners LP Receives $32.25 Consensus Price Target from Analysts
SL Green Realty Corp  Receives $93.85 Average Price Target from Brokerages
SL Green Realty Corp Receives $93.85 Average Price Target from Brokerages
HC Wainwright Reaffirms Buy Rating for Y-mAbs Therapeutics
HC Wainwright Reaffirms Buy Rating for Y-mAbs Therapeutics
Analysts Set SS&C Technologies Holdings, Inc.  Price Target at $65.91
Analysts Set SS&C Technologies Holdings, Inc. Price Target at $65.91


© 2006-2019 Ticker Report